Inactive Instrument

Calendar Acasti Pharma Inc. Toronto S.E.

Equities

ACST

CA00430K8730

Chart calendar Acasti Pharma Inc.

c1786dadde55555b2ea1cb2ecb19e.HDpaArl19DPp2p0SVzW1sd3ZEshHAqqw7BdA4jBY_O8.aHsgbf8XgFuIsKV6JVfdwJXvdKUpXcDmu1YVrHody75kbSJB1RjESpig7g~5a79ad53a7ba69ba2aaa2547e4305836

Upcoming events on Acasti Pharma Inc.

2024-06-17 Q4 2024 Earnings Release (Projected)
2024-08-07 Q1 2025 Earnings Release (Projected)
2024-11-10 Q2 2025 Earnings Release (Projected)
2025-02-16 Q3 2025 Earnings Release (Projected)

Past events on Acasti Pharma Inc.

2024-02-12 08:00 am Q3 2024 Earnings Release
2024-02-07 International Stroke Conference
2024-01-09 LifeSci Partners Corporate Access Event
2024-01-07 Bio One On One Partnering Conference
2024-01-06 Sachs Neuroscience Innovation Forum
2023-11-13 08:00 am Q2 2024 Earnings Release
2023-10-11 02:00 pm Investor Meeting - Key Openion Leader
2023-10-10 01:00 pm Annual General Meeting
2023-09-11 02:00 pm H.C. Wainwright Global Investment Conference
2023-08-16 06:00 pm Neurocritical Care Society Meeting - Poster Number: 247
2023-08-11 07:00 am Q1 2024 Earnings Release
2023-06-23 07:00 am Q4 2023 Earnings Release
2023-05-18 02:00 pm Lytham Partners Spring Investor Conference - Panel
2023-05-18 09:00 am Lytham Partners Spring Investor Conference
2023-03-13 08:40 am Oppenheimer Healthcare Conference
2023-02-14 01:00 pm Q3 2023 Earnings Call
2023-02-14 07:00 am Q3 2023 Earnings Release
2023-01-31 09:00 am Lytham Partners virtual Investor Select Conference
2023-01-18 03:15 pm Sidoti Micro-Cap Virtual Conference
2023-01-10 04:30 pm GTX-101 and GTX-102 Phase 1 PK Studies Results Call

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million CAD
Released
Forecast
Spread
-42,2
-18,3
-130.18%
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

-18,9

EBIT
Million CAD
Released
Forecast
Spread
-45,0
-43,9
-2.44%
-30,6
-35,9
14.87%
0,00


-20,3
-21,5
5.92%
-24,6
-27,2
9.74%

-16,3

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
0,00
0,00
-
-34,9
-68,1
48.68%
0,00


-13,6
-14,9
8.76%
-68,4
-27,2
-151.55%

-19,6

Net income
Million CAD
Released
Forecast
Spread
0,00
0,00
-
-34,9
-68,1
48.68%
-24,3


-12,8
-14,9
14.41%
-55,9
-26,3
-112.7%

-18,4

EPS
CAD
Released
Forecast
Spread
0,00
0,00
-
-19,7
-38,2
48.43%
-10,1


-2,09
-1,07
-96.04%
-7,53
-3,56
-111.24%

-1,94

Announcement Date26/06/1929/06/2022/06/2121/06/2223/06/23-

Quarterly results

Fiscal PeriodMarch 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million CAD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBITDA
Million CAD
Released
Forecast
Spread


















-4,10
-3,24
-26.37%

-4,97


-4,97


-5,64


-5,64


-5,64

EBIT
Million CAD
Released
Forecast
Spread
-5,67
-4,53
-25.4%
-5,72
-7,64
25.15%
-5,67
-7,79
27.27%
-6,01
-8,44
28.8%
-5,97
-6,63
10%
-2,89
-3,27
11.46%
-4,10
-3,51
-16.69%

-5,38


-5,38


-6,05


-6,05


-6,05

Earnings before Tax (EBT)
Million CAD
Released
Forecast
Spread
-4,79
-4,53
-5.89%
-5,91
-7,64
22.62%
-5,56
-7,86
29.25%
-50,0
-8,44
-491.99%
-5,78
-6,40
9.67%
-5,14
-3,10
-66.12%
-3,50
-3,51
0.34%

-5,38


-5,38


-6,05


-6,05


-6,05

Net income
Million CAD
Released
Forecast
Spread
-4,79
-4,53
-5.89%
-5,07
-7,64
33.64%
-5,19
-7,74
32.92%
-38,3
-8,44
-353.64%
-5,39
-6,21
13.13%
-4,53
-3,00
-50.7%
-3,22
-3,55
9.42%

-5,38


-5,38


-6,05


-6,05


-6,05

EPS
CAD
Released
Forecast
Spread
-0,69
-0,62
-11.31%
-0,31
-1,00
68.86%
-0,72
-1,02
29.25%
-5,15
-1,13
-356.66%
-0,72
-0,84
13.44%
-0,59
-0,40
-50.59%
-0,28
-0,31
9.09%

-0,47


-0,36


-0,42


-0,42


-0,32

Announcement Date14/02/2221/06/2214/02/2323/06/2311/08/2313/11/2312/02/24-----